C4ORF14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.628000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.016000E-01
Normal-vs-Stage2
8.595600E-01
Normal-vs-Stage3
2.361400E-01
Normal-vs-Stage4
3.566600E-01
Stage1-vs-Stage2
8.517000E-01
Stage1-vs-Stage3
2.988800E-01
Stage1-vs-Stage4
1.553580E-01
Stage2-vs-Stage3
2.050200E-01
Stage2-vs-Stage4
5.361800E-02
Stage3-vs-Stage4
1.037610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.948800E-01
Normal-vs-AfricanAmerican
1.665370E-01
Normal-vs-Asian
7.551200E-01
Caucasian-vs-AfricanAmerican
3.475200E-01
Caucasian-vs-Asian
6.911600E-01
AfricanAmerican-vs-Asian
5.724600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.180600E-01
Normal-vs-Female
9.014200E-01
Male-vs-Female
7.299800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.662400E-02
Normal-vs-Age(41-60Yrs)
8.758800E-01
Normal-vs-Age(61-80Yrs)
6.965400E-01
Normal-vs-Age(81-100Yrs)
8.646800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.929220E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.841200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.344000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.690300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.546000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.647800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.351200E-01
Normal-vs-Daily Drinker
4.421600E-01
Normal-vs-Weekly Drinker
9.051000E-01
Normal-vs-Occasional Drinker
6.986800E-01
Normal-vs-Social Drinker
8.886400E-01
Non Drinker-vs-Daily Drinker
2.731800E-01
Non Drinker-vs-Weekly Drinker
9.300200E-01
Non Drinker-vs-Occasional Drinker
2.411000E-01
Non Drinker-vs-Social Drinker
5.122000E-01
Daily Drinker-vs-Weekly Drinker
3.671200E-01
Daily Drinker-vs-Occasional Drinker
3.624000E-02
Daily Drinker-vs-Social Drinker
1.384580E-01
Weekly Drinker-vs-Occasional Drinker
4.248200E-01
Weekly Drinker-vs-Social Drinker
6.768000E-01
Occasional Drinker-vs-Social Drinker
7.333600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.577000E-01
Normal-vs-Grade 2
9.507200E-01
Normal-vs-Grade 3
9.387000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.350300E-02
Grade 1-vs-Grade 3
8.784300E-04
Grade 1-vs-Grade 4
8.577000E-01
Grade 2-vs-Grade 3
8.758900E-03
Grade 2-vs-Grade 4
9.507200E-01
Grade 3-vs-Grade 4
9.387000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.256400E-01
Normal-vs-NonDiabetic
8.817200E-01
Diabetic-vs-NonDiabetic
4.990200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.409800E-01
Normal-vs-NoPancreatitis
8.241000E-01
Pancreatitis-vs-NoPancreatitis
4.978200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.817600E-01
Normal-vs-N1
8.530400E-01
N0-vs-N1
5.874000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.062800E-01
Normal-vs-TP53-NonMutant
8.951000E-01
TP53-Mutant-vs-TP53-NonMutant
6.561900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
